8 withdrawn. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Withdrawn 8 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension SDP-133, Lumigan - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Sun Pharmaceutical Industries Limited | 2019-06-10 | 2021-11-19 | |
| Pilocarpine After Combined Cataract/Trabectome Surgery Pilocarpine, Ofloxacin, Prednisolone - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Montefiore Medical Center | 2019-06-05 | 2022-04-07 | |
| Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension dorzolamide hydrochloride 2.0%/brimonidine tartrate 0.2%/timolol 0.5% ophthalmic solution - Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Allergan | 2013-07-01 | 2013-07-18 | |
| Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH Latanoprost+Brinzolamide combination, Latanoprost - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Adapt Produtos Oftalmológicos Ltda. | 2012-12-01 | 2014-12-11 | |
| Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% Travoprost Ophthalmic Solution, 0.004% (New Formulation), TRAVATAN® - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Alcon Research | 2011-11-01 | 2012-02-10 | |
| Safety and Efficacy Study of DuoTrav APS Versus DuoTrav DuoTrav APS, DuoTrav - Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Alcon Research | 2009-03-01 | 2012-01-18 | |
| A Multi-Dose Study With a Treatment for Open-Angle Glaucoma Anecortave Acetate, Placebo - Open-Angle Glaucoma | Phase 2 / Phase 3 | Withdrawn | Alcon Research | 2008-05-01 | 2012-05-30 | |
| Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device Xalatan - Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Withdrawn | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2021-02-02 |
Glaucoma, Open-Angle (7) · Ocular Hypertension (7)
Eye Diseases (8) · Ocular Hypertension (1)
Latanoprost (2) · Ophthalmic Solutions (2) · Bimatoprost (1) · Brimonidine Tartrate (1) · Duotrav (1) · Methylprednisolone (1) · Ofloxacin (1) · Pilocarpine (1) · Prednisolone (1) · Timolol (1) · Travoprost (1) · anecortave acetate (1) · brinzolamide (1) · dorzolamide (1)
Alcon Research (3) · Adapt Produtos Oftalmológicos Ltda. (1) · Allergan (1) · Montefiore Medical Center (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Sun Pharmaceutical Industries Limited (1)
Brazil (1) · United States (1)